ライフサイエンスコーパス: blood collection

1 sease activity were evaluated at the time of blood collection.

2 glycemic control in the months leading up to blood collection.

3 es diagnosed within approximately 4 years of blood collection.

4 fasting status, and time of day and month of blood collection.

5 ts is affected by the anticoagulant used for blood collection.

6 quately characterized in the month preceding blood collection.

7 ble if the plasma is separated within 6 h of blood collection.

8 clinical evidence of disease at the time of blood collection.

9 lection to assess discomfort associated with blood collection.

10 gs were obtained within three hours of whole blood collection.

11 en who were generally healthy at the time of blood collection.

12 enter, age, sex, fasting status, and time of blood collection.

13 $1/sample and analysis time was 30 min after blood collection.

14 cing the risk due to exposure to needles and blood collection.

15 race, ethnicity, cancer status, and date of blood collection.

16 es were generally completed within 9 days of blood collection.

17 ction to cases diagnosed 8 to 13 years after blood collection.

18 hed on age, year of birth, race, and time of blood collection.

19 The mean age was 58.7 y at blood collection.

20 iagnosed approximately 8 years or more after blood collection.

21 onnaire administered every 4 years, prior to blood collection.

22 , and time of day and duration of fasting at blood collection.

23 to cases on age at randomization and date of blood collection.

24 sting, exhaled nitric oxide measurement, and blood collection.

25 ncer cases were randomly sampled by month of blood collection.

26 a diagnosis of prostate cancer 5 years after blood collection.

27 controls by year of birth, race, and time of blood collection.

28 fasting status, and time of day and month of blood collection.

29 e, education, income, and gestational age at blood collection.

30 ls by age, sex, race/ethnicity, and dates of blood collection.

31 enzymatic breakdown generated after patient blood collection.

32 eported adverse events or complications from blood collections.

33 m 3 European birth cohorts (offspring age at blood collection: 16, 17, and 31 years).

34 rol was matched to each case on age, date of blood collection (1974-2006), sex, and race/ethnicity (n

35 gnosed cardiovascular disease at the time of blood collection, 266 had nonfatal myocardial infarction

36 and organ transplantation was recognized and blood collection agencies implemented West Nile virus nu

37 1 patients with NHL diagnosed 5+ years after blood collection and 301 control patients within the Pro

38 xyvitamin D after standardizing for month of blood collection and adjusting for covariates.

39 postmenopausal breast cancer diagnosed after blood collection and before June 2000, in which there we

40 participants was independent of time between blood collection and diagnosis and was observed more tha

41 d to stage or grade of disease, time between blood collection and diagnosis, age and year of diagnosi

42 We compared how different methods of blood collection and handling affect isolation of this p

43 Between the first blood collection and June 2010, 2188 breast cancer cases

44 The average time between blood collection and MS onset was 4 years.

45 We also determined the influence of blood collection and NGS preparations on the miRNA patte

46 gnostic study of blood samples from national blood collection and prion disease centers in the United

47 e use, body mass index, and the time between blood collection and RA onset, we found that the daily a

48 age, case patients were 61.5 years of age at blood collection and received a diagnosis of prostate ca

49 Patients visited the clinic for predose blood collection and safety evaluation at baseline (days

50 dent cases in the WHS, the mean time between blood collection and the onset of RA symptoms was 5.2 ye

51 y for applications in the field where venous blood collection and timely shipment of labile blood sam

52 ated with age, state of residence, season of blood collection, and body mass index but not with tumor

53 controls matched by center, gender, date of blood collection, and date of birth.

54 by age, sex, study center, date and time of blood collection, and fasting status.

55 at baseline, study center, date and time of blood collection, and fasting status.

56 ted for matching factors, gestational age at blood collection, and prepregnancy body mass index.

57 atio and matched with regard to age, date of blood collection, and smoking status.

58 ere observed conducting venous and capillary blood collections, and pre- and posttests were offered d

59 Galacomannans were also found in blood collection anticoagulant and platelet additive sol

60 4.8 g fat), or whole (7.9 g fat) milk before blood collection at regular intervals for 72 h.

61 d investigational practices surrounding cord blood collection, banking, and use.

62 significantly associated with younger age at blood collection, being premenopausal, having an older a

63 ardial infarction (fatal and nonfatal) after blood collection but before July 1998.

64 Disruption of blood collection by political unrest, natural disasters

65 g on probing (BOP) were collected on special blood collection cards and analyzed for HbA1c levels in

66 The valuable role that blood collection centers can play in increasing the samp

67 ctDNA was undetectable in the post-surgical blood collection, consistent with their lack of detectab

68 sex, birth date (within 1 year), center, and blood collection date (within 15 days).

69 93-2005) and 428 controls matched on age and blood collection date within the Alpha-Tocopherol, Beta-

70 ched on race, sex, age, enrollment site, and blood collection date.

71 included age, latitude, race/ethnicity, and blood collection date.

72 We conducted 24-h serial blood collections during the baseline and intervention t

73 and 1 severe) were reported to the regional blood collection facility.

74 During the 12 mo before blood collection, food intakes were assessed repeatedly

75 vity diary; and 4) clinical measurements and blood collection for 25(OH)D determination.

76 These measurements and blood collection for clinical biochemical markers were p

77 tric assessments were conducted, followed by blood collection for the quantification of seven serum P

78 e studied using a shed blood model involving blood collection from skin incisions made using standard

79 those who initiated aspirin/NSAID use after blood collection had significant reductions in subsequen

80 Prior to blood collection in 1993-1994, physical activity and tel

81 to filter paper have eased the difficulty of blood collection in resource-limited settings.

82 is circumvents the need for venipuncture and blood collection in specialized vials by a phlebotomist

83 20s and the development of plastic packs for blood collection in the 1960s laid the groundwork for pl

84 ong subjects diagnosed closer to the date of blood collection in the two cohorts with sufficient case

85 Between blood collections in 1996-1999 and 2007, we ascertained

86 ion of B. henselae and suggest that, for cat blood, collection in tubes containing EDTA and subsequen

87 d 2,257 controls (matched on age and date at blood collection) in the Finnish Maternity Cohort, a coh

88 We examined heterogeneity by time since blood collection (</= 3, 4- </= 6, and > 6 years) in str

89 mic score can be obtained within 12 hours of blood collection, making it available for clinical decis

90 Thus, disruptive procedures of blood collection may result in gross overestimates in th

91 n products in plasma are stable with routine blood collection methods and reflect oxidation in food,

92 hnicity, smoking, diagnosis year, stage, and blood collection month.

93 al closure (n = 3) or removal of pericardial blood collection (n = 1).

94 among cases diagnosed 5 or more years after blood collection (n = 238) (for highest quintile vs. low

95 nanoparticle system, with an assay time from blood collection of 3.5 hours, may be a promising platfo

96 mong cases diagnosed six or more years after blood collection (OR, 0.60; 95% CI, 0.40-0.90; Ptrend =

97 , smoking, exercise, time between waking and blood collection, or season.

98 cluding patients diagnosed within 5 years of blood collection (P for trend = .04); the multivariate H

99 for trend = 0.02) and duration of fasting at blood collection (P for trend = 0.002).

100 To define the optimal blood collection parameters for plasma human immunodefic

101 Here, we show that standard blood collection procedures rapidly change the transcrip

102 s" (pools of 16 to 24 donations) by the main blood-collection programs in the United States during th

103 erum collected by venipuncture and capillary blood collection protocols.

104 ge, fasting status, time of day and month of blood collection, race/ethnicity, and timing of blood dr

105 cases diagnosed within 4 years (median) from blood collection (rate ratio = 0.17, 95% confidence inte

106 CC after adjustment for season of and age at blood collection, sex, and country of recruitment (odds

107 After controlling for age at blood collection, smoking, parity and duration of breast

108 ases diagnosed longer than 6 years following blood collection (sTNF-R1: OR = 2.1, 95% CI: 1.0-4.0, P(

109 Autologous blood collection techniques, including preoperative auto

110 ta on UVR and other factors near the time of blood collection, the ability to explain 25(OH)D was mod

111 ime; among cases diagnosed >or=8 years after blood collection, the adjusted RR was 3.47 (95% CI, 1.48

112 among those vaccinated > or =15 years before blood collection, the GMT was 58 (95% CI, 44-76) (P = .0

113 However, in men who had fasted (>3 h) at blood collection, the odds ratio for prostate cancer was

114 women less than 50 years old at the time of blood collection, the relative risk was 4.58 (1.75-12.0;

115 g: the potential for in vitro artifacts with blood collection, the technical limitations of clot-base

116 ociations weakened with increasing time from blood collection to case diagnosis and were null for cas

117 ion was unchanged by the length of time from blood collection to case diagnosis.

118 age at diagnosis, body mass index, time from blood collection to diagnosis, or calcium intake.

119 Median time from blood collection to patient notification of result was 6

120 the trypsin digestion with acid, the type of blood collection tube, different hemolysis levels, diffe

121 ole blood RNA collection, PAXgene and Tempus blood collection tubes, and each comes with their own RN

122 The effects of three types of blood collection tubes, two storage temperatures, five p

123 ining (2 plain and 2 self-sealing) capillary blood collection tubes.

124 s of anesthesia, ureteral urine collections, blood collections, volume replacement, and functional st

125 Median age at blood collection was 63 years.

126 Blood collection was completed in the same year.

127 resence of a vaccination scar at the time of blood collection was not determined.

128 In the ANH group, intraoperative blood collection was performed to a target hemoglobin of

129 In the ANH group, intraoperative blood collection was performed to a target hemoglobin of

130 RNA from peripheral-blood collection was used for DNA microarray analysis.

131 es restricted to pregnancies conceived after blood collection were consistent with the main analyses.

132 Participants diagnosed within 2 years of blood collection were excluded.

133 Different routes of blood collection were tested to identify a method to rep

134 ury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-inju

135 Blood collections were used to measure blood glucose, ba

136 d month of and fasting status at the time of blood collection with controls from the same cohort.